Shares rose after strong clinical data strengthened the case for its $10.6 billion Nuvalent acquisition and broader push to rebuild oncology around lung cancer.
Zacks Investment Research on MSN
GSK presents Jideytro data for potential use in first-line NSCLC
GSK plc GSK announced positive data from the registrational phase I/II ARROS-1 study evaluating its oncology drug, Jideytro ...
GSK shares climbed after the company reported encouraging clinical trial results for two lung cancer treatments, strengthening its oncology strategy despite mixed analyst views on the stock.
GSK is sticking to its plan to gradually monetize its stake in Haleon, the consumer health business the British pharma giant spun off in 2022. GSK has collected about 978 million pounds ($1.24 billion ...
Executive says pharmaceutical company is investing in shared data infrastructure British pharmaceutical company GSK is ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced the ...
GlaxoSmithKline and Madison, Wisconsin-based Propeller Health announced a partnership today in which Propeller will develop and manufacture a custom sensor for GSK's Ellipta inhaler for COPD patients.
By Puyaan Singh and Bhanvi Satija Sept 11 (Reuters) - GSK said on Friday it will be shutting down a vaccine factory in ...
BRENTFORD, England, Nov. 16, 2021 /PRNewswire/ -- GSK NEXT, the disruptive innovation arm of the science-led global consumer healthcare company GSK is excited to announce the six startups joining its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results